Home/Products /gemcitabine-1000mg-injection

GEMTYLE 1000 Injection: Gemcitabine 1000 mg

Name: GEMTYLE 1000: Gemcitabine 1000 mg Injection | Top PCD Pharma Franchise in Oncology Segment
Brand: Gemtyle 1000 Injection
Rating: 4.8 (150 reviews)

Multi-Spectrum Efficacy: A Core Component in Cancer Protocols

The Mechanism: Inhibiting DNA Synthesis and Inducing Apoptosis

Standard of Care in Pancreatic, Lung, and Breast Cancer Management

High-Value Market: Injectable Oncology Demand in India

Secure Your Future: GEMTYLE 100 PCD Pharma Franchise with Monopoly

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

GEMTYLE 100 Gemcitabine 1000 mg Injection vial

Mechanism of action for Gemcitabine in cancer cells

Injectable chemotherapy product for oncology treatment

High-profit PCD Pharma franchise for anti-cancer drugs

Gemcitabine injection for Pancreatic and Lung Cancer

Gemtyle 1000 Injection

Composition : Gemcitabine 1000mg Injection

Dosage Form : Injection

Packaging Type : Vial

Packaging : 1gm

Price : ₹1/-

Please Contact For Best Price

GEMTYLE 1000 Injection (Gemcitabine 1000 mg) is a widely used and indispensable cytotoxic chemotherapy agent in modern oncology. Classified as an antimetabolite (a pyrimidine analog), it is crucial for the treatment of several aggressive malignancies, including: Pancreatic Cancer (as a monotherapy or in combination), Non-Small Cell Lung Cancer (NSCLC) (in combination with cisplatin), Ovarian Cancer (in combination with carboplatin), and Metastatic Breast Cancer (in combination with paclitaxel).

Gemcitabine works as a prodrug, converting inside the cancer cell into active metabolites that inhibit DNA synthesis (masked chain termination) and block the enzyme ribonucleotide reductase. This dual action effectively slows or stops the growth and spread of cancer cells.

The demand for high-quality, generic injectable oncology products like Gemcitabine is consistently high, driven by the rising prevalence of cancer globally and the necessity of chemotherapy in standard treatment protocols. This places GEMTYLE 1000 in a high-demand, high-growth market segment. We offer a lucrative PCD Pharma Franchise opportunity with exclusive Monopoly Rights for Gemcitabine 1000 mg, ensuring competitive pricing, quality assurance, and comprehensive promotional support for targeted distribution to hospitals and oncology centers.

About the Product

May cause headache, muscle pain, nausea, abdominal discomfort, or mild liver enzyme elevation. Rarely, serious muscle problems (myopathy or rhabdomyolysis) may occur.

Primary hypercholesterolemia Mixed dyslipidemia Familial hypercholesterolemia Prevention of cardiovascular disease in high-risk patients

Take under medical supervision, preferably once daily, with or without food. Regular liver function and lipid profile monitoring is advised. Inform your doctor about any muscle pain, weakness, or pre-existing liver/kidney conditions. Avoid excessive alcohol intake.

Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.